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1. Introduction 
Evidence is accumulating to suggest hat the phos- 
phorylation of histone and non&stone chromosomal 
proteins plays a key role in the regulation of the eukar- 
yotic gene expression. Many of the non-h&tone chro- 
mosomal proteins are phosphoproteins and their phos- 
phorylation is catalysed by protein kinases including 
both cyclic AMP-dependent and -independent protein 
kinases [l-3]. Two cyclic AMP-independent nuclear 
protein kinases, NI and NII [4], have been purified 
from rat liver nuclei and characterized [5,6]_ These 
two kinases, involved mainly in the phosphorylat~on 
of non-histone chromosomal proteins, are not regu- 
lated by direct acting effecters [7]. Cytosol cyclic 
AMP-independent protein kinases from rabbit reti- 
culocytes and bovine adrenal cortex were found to be 
inhibited by glycosaminoglycan [8,9]. We now report 
that nuclear protein kinase NII is also selectively inhib- 
ited by heparin, a glycosa~noglycan, when either 
casein or phosvitin is used as the substrate, while no 
inhibition occurs with histone. Histone is rather effec- 
tive in the recovery of the enzyme activity inhibited 
by heparin. A similar release of inhibiton by heparin 
was seen with spermine and spermidine, but not with 
putrescine. Analysis with heparin-Sepharose affinity 
chromatography suggested that polyamines exert the 
effect without ~fluencing the binding between heparin 
and the enzyme. 
2. Mate~~s and methods 
[T-~~P]ATP was prepared as in [lo]. Putrescine 
dihydrochloride, spermidine trihydrochloride, sper- 
mine tetrahydrochlo~de, casein, histone, phos~tin 
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and phenylmethylsulfonyl fluoride (PMSF) were pur- 
chased from Sigma. Heparin was from Nakarai Chemi- 
cals, Kyoto. DEAE-Sephadex A-25, activated CH- 
Sepharose 4B, Sephacryl S-300 superfine and heparin- 
Sepharose CL-6B were from Pharmacia. Hydroxyap- 
atite was from Bio-Rad. Phosphocellulose was from 
Whatman. Spermidine-Sepharose was prepared as in 
[111* 
2 .I . Extraction and purification of nuclear protein 
kinases 
Nuclei were isolated from rat liver (130 g) as in [ 121 
with slight modi~cation. Details of the procedure will 
be reported elsewhere (131. The purif?ed nuclei were 
extracted twice with 75 mM NaCl, 25 mM EDTA 
(pH 8.0), 0.5 mM PMSF and successively 6 times with 
10 mM Tris-I-ICI (pH 8.0), 0.5 mM PMSF. Combined 
extracts were used for purification of protein kinases. 
Extracted proteins (700 mg) were dialysed against 
50 mM Tris-HCl (PH S.O), 0.1 mM EDTA, 10% 
glycerol, 10 mM ~-mercaptoe~~anol and 0.5 mM PMSF 
(buffer A) containing 0.3 M NaCl and applied to a 
phosphocellulose column (2.5 X 10 cm) equilibrated 
with the same buffer. Cyclic AMP~ndependent protein 
kinase activities were eluted with a linear gradient from 
0.3-l .O M NaCl in buffer A. Active fractions were 
directly applied to a hydroxyapatite column (1.6 X 
6 cm) equ~brated with buffer A containing 1 .O M 
NaCl. With this step, protein kinases were separated 
into NI and NH (131. The flow-through fraction was 
used as a source for protein kinase NI. NII was eluted 
at 140 mM phosphate with a linear gradient from 
1 O-500 mM potassium phosphate buffer (pH 7.4) 
containing the same additives. NH kinase was pre- 
cipitated with ammonium sulfate at 80% saturation, 
dissolved in 3 ml buffer A containing 1 .O M NaCl and 
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subjected to a Sephacryl S-300 column (2.5 X 88 cm) 
equilibrated with buffer A containing 1 .O M NaCl. The 
active fractions were dialysed against buffer A con- 
taining 0.1 M NaCl and applied to a DEAE-Sephadex 
A-25 column (1.6 X 3 .O cm) equilibrated with the 
same buffer. NII kinase was recovered at 280mM NaCl 
with a linear gradient elution from 0.1-0.5 M NaCl. 
The protein kinase was dialysed against buffer A con- 
taining 0.1 M NaCl and applied to a spermidine-column 
(I .5 X 2.0 cm) equilibrated with buffer A containing 
0.1 M NaCl. NII kinase was eluted at 330 mM NaCl 
with a linear gradient elution from 0.1-l .O M NaCl 
in buffer A and used as NH preparation. NII enzyme 
was purified -2000-fold from nuclear extracts. 
2.2. Assay of protein kinase activity 
The standard reaction mixture (100 ~1) contained 
50 mM Tris-HCl (pH 7.4), 5 mM MgC&, 10 mM 
~-mercaptoethanol, 2 mg substrate~ml, 0.1 mM 
[r_32P] ATP (I 00 000 cpm/nmol) and enzyme. After 
the incubation at 30°C for 10 min, the reaction was 
terminated by transferring 100 E.rl of aliquots onto 
Whatman 3 MM filters (1.5 X 3 .O cm) which were then 
processed as in [4]. 
3. Results 
3.1. Effect of h eparin on nuclear cyclic AMP-inde- 
pendent protein kinases 
As shown in fig.1, protein kinase NH was strongly 
inhibited by heparin when either casein or phosvitin 
was used as the substrate. Inhibition of SO% was seen 
with 100 ng/ml and 30 ng/ml of heparin for casein 
and phosvitin, respectively. In contrast, heparin at 
GO0 pg/rnl showed no inhibition when histone was 
used as a substrate, although histone is a poor phos- 
phate acceptor of protein kinase NH [14]. There was 
no inhibitory effect of heparin (<I 0 @g/ml) on nuclear 
protein kinase NI, with any substrate used (not shown). 
To determine the kinetics of heparin inhibition, the 
rate of phosphorylation by NII was studied at various 
concentrations of casein or ATPusing 3 different con- 
centrat~ons of heparin. A double reciprocal plot of 
the data revealed that heparin is a competitive inhib- 
itor ofprotein kinase NII with respect o casein (fig.2), 
but is noncompetitive toward ATP (not shown). 
These results are consistent with those of casein kinases 
from rabbit reticulocytes and bovine adrenal cortex 
cytosol [8,9]. 
3.2. Effect ofpolya~i~es and histone on the jnhibjtion 
of protein kinase NII by heparin 
We have found that protein kinase NII is stimulated 
7.5-fold with 2 mM spermine, 6.5-fold with 6 mM 
spermidine and 1.4-fold with 10 mM putrescine when 
casein was used as a substrate [ 131. These findings 
prompted further investigation of the effect of poly- 
amines on the heparin inhibition of protein kinase 
NII. The inhibitory effect of heparin was released 
with spermine and spermidine, but not with putrescine 
(Gl 0 mM), as shown in fig.3. Spermidine and spermine 
reversed the heparin inhibition even if added after the 
enzyme was incubated with heparin at 4°C for 1 h 
(not shown). 
Fig.1. Effect of heparin on nuclear protein kinase NIL Pro- 
tein kinase activity was assayed in the standard reaction mix- 
ture containing 10 ng enzyme, 2 mg histone/mI (=), casein 
(0) or phosvitin (o), and the indicated amount of heparin. 
The values assayed without heparin were taken as 100%. 
1 2 
~(mg/rnlT' lo 1 5 
Fig.2. Lineweaver-Burk plots for the ~hibition of protein 
kinase NII by heparin. Assays were carried out in the standard 
reaction mixture containing 10 ng enzyme, various concen- 
trations of casein from O.l- 10.0 mg/mI in the absence (A) 
and presence of heparin. Iteparin was 0.1 pgfml (=) and 
0.5 jig/ml (0). 
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Fig.3. Effect of polyamines on the ~hibition of protein kinase 
NH by heparin. Assays were performed in the standard reac- 
tion mixture containing 10 ng enzyme, 0.25 Mg heparin/ml, 
2 mg casein/ml and the indicated concentrations of spermine 
(*), spermidine (A) and putrescine (=). 100% activity corre- 
sponds to the value assayed in the absence of heparin and 
polyamine. 
As heparin solubihzes chromatin through the inter- 
action with histones [I 5 J, we examined the effect of 
histone on the inhibition of protein kinase NII by 
heparin. Histone stimulated the protein kinase NH 
activity 2.3-fold at 0.4 mg[ml and the in~bition by 
heparin disappeared with increasing doses of histone 
(fig.4). 
3.3. The re~~on~i~ along ~o~ya~ine~, repaid and 
protein kinase NIZ 
To determine the mechanism of reversal of the hep- 
arin inhibition by polyamines, the interaction among 
polyamines, heparin and enzyme was assessed using 
heparin-Sepharose affinity chromatography. Protein 
Fig.4. Effect of histone on the haparin inhibition of NIL 
Protein kinase activity was measured in the standard reac- 
tion mixture containing 10 ng enzyme, 2 mg casein/ml and 
the indicated amount of histone in the absence (0) and pres- 
ence (0) of heparin (0.2 pg/ml). The value assayed in the 









Fig.5. Heparin-Sepharose affinity chromatography. (A) Puri- 
fied protein kinase NH in buffer A containing 0.1 M NaCl 
was applied to a heparin-Sepharose column (1 .O X 1.5 cm) 
~qu~ibrated with buffer A containing 0.1 M NaCI. The 
column was washed with buffer A containing 0.1 M NaCl 
and eluted with a 50 ml linear gradient from 0.1-1.5 M 
NaCl in buffer A. (B) Purified protein kinase NH in buffer 
A containing 10 mM spermidine was applied to a heparin 
column (1 .O X 1.5 cm) equilibrated with buffer A conning 
10 mM spermidine. After wash with buffer A containing 
10 mM spermidine, stepwise elution was performed with 
buffer A containing 50 mM (a), 100 mM (b), 150 mM (c), 
and 200 mM (d) spermidine and fiially 1.5 M NaCl (e). 
Fractions of 1 ml were collected at 20 ml/h. Protein kinase 
activity (0) was assayed in the standard reaction mixture 
containing 2 mg casein/ml, 0.15 M NaCl and enzyme. 
kinase NII bound to the column and eluted at 
0.65-0.84 M NaCl in buffer A as depicted in figSA 
or 5 mg/ml of heparin in buffer A. It is conceivable 
that ,if poIyamine affects the binding between heparin 
and enzyme, a low concentration of polyamine should 
not only prevent the adherence of enzyme to a heparin- 
column but should also release the enzyme from the 
column. Contrary to our expectations, the enzyme in 
buffer A containing IO mM spermidine adhered to 
the heparin column equilibrated with buffer A con- 
taining 10 mM spermidine. Once the enzyme had bound 
to the hepa~~olumn, it eluted only with buffer A 
containing 150 mM spermidine, which is almost the 
same ionic strength as that of NaCl used for the elu- 
tion (fig.SB). These results suggest hat spermidine 
does not alter the binding between heparin and the 
enzyme. 
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4. Discussion 
Efeparin is a highly sulfated ~lyc~sa~no~l~can 
with anticoagulant activity and selectively interacts 
with different enzymes to bring about significant 
changes in their activities. Although heparin is a con- 
stituent of various tissues, particularly liver and lung, 
little is known of precise intracellular distributions 
of glycosaminoglycan I: 15 1. Several workers have 
shown that glycosaminoglycan might be associated 
with cell nuclei, in s~gni~cant a~nounts [ 15,171. Close 
interaction of glyco~~n~glycan with nuclear com- 
ponents is also suggested by the facts that heparin 
induces changes in nuclei by loosening the c~rorna~i~ 
structure and alters the activities of enzymes involved 
in nucleic acid metabolism, such as DNA polymerase, 
RNA palymerase and ribonuclease [I 51. This study 
ha.s shown that heparin selectively inhibits nuclear 
protein kinase NII, which may play an impartant role 
in the regulation of gene activity by ~hos~hory~at~g 
the high mobility group (HMG) and other non-histone 
c~romo~omal proteins [I 8,19], It is generally consid- 
ered that the inhibition of enzyme activity by heparin 
is not mediated by simple ionic interaction but pre- 
sumably by ~~yrne-~h~~~tor interaction [20,211. 
This also seems pertinent to protein k&se NII 
because NFI enzyme, despite being an acidic protein, 
binds to a polyanionic heparincolumn and is selec- 
tively eluted by heparin. 
Heparin-Sepharose affinity chromatography 
appears ta be feasible for assessing the interaction 
among polyamines, heparin and enzyme as well as 
for purification of protein kinases inhibited by heparin. 
The fact that ~olya~Res affect neither the adherence 
nor the release of the enzyme from the column sug- 
gests that ~oly~i~es reverse the inhibitory effect of 
heparin without affec~~g the bi~d~~~ between protein 
kinase NII and heparin. In [22] polyamines dissociated 
and endogenous inhibitor from the casein kinase of 
adrenal cortex cytosol. Therefore, the interaction 
among nuclear protein kinase NH, heparin, and PO& 
amines might be different from that of the casein 
kiase with an endagenous inhibitor and spermine. 
Nuclear protein kinase NII is not regulated by cyclic 
AMP, cyclic GMP or calcium [ 141. Heparin could bo 
a ~h~~s~o~o~ca~ regulator, ~~teract~~g with poly~~~es 
and histones, of nuclear protein kinase NH. 
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